Real-time enrollment status for this thyroid eye disease clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT06812325 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Thyroid Eye Disease |
| Phase | Clinical Trial |
| Target Enrollment | 284 participants |
| Active Locations | 30 sites in the US |
| Sponsor | Viridian Therapeutics, Inc. |
| Last Updated on CT.gov | December 18, 2025 (Dec 18, 2025) |
As of March 2, 2026: Clinical trial NCT06812325 is currently active_not_recruiting participants. This clinical trial study for thyroid eye disease is not currently accepting new participants at 30 locations across the United States. The study is sponsored by Viridian Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06812325 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 30 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06812325 was last updated Dec 18, 2025 (December 18, 2025). HelloStudys verifies this status automatically.